{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:58:06Z","timestamp":1787068686736,"version":"build-2736575974"},"reference-count":51,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jpm-2024-0473_abs_001\">\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Vasa previa (VP) is a serious pregnancy complication in which fetal vessels, unprotected by the umbilical cord, run across or within close proximity to the internal cervical os, which can potentially result in fetal exsanguination in the event of membrane rupture. There is global consensus that women with antenatally diagnosed VP should have caesarean delivery prior to onset of labour to prevent the catastrophic complications of VP. However, there is variability in the approach to management of these women antenatally, particularly regarding hospitalisation and timing of steroid administration and delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpm-2024-0473_abs_002\">\n                    <jats:title>Content<\/jats:title>\n                    <jats:p>In this review, we aim to compare the VP guidelines of four prominent obstetric advisory bodies: The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG), The Royal College of Obstetricians and Gynaecologists (RCOG), The Society for Maternal-Fetal Medicine (SMFM) and The Society of Obstetricians and Gynaecologists of Canada (SOGC) with a particular focus on antenatal hospitalisation, administration of steroids, and timing of birth in asymptomatic patients. We also aim to evaluate the evidence cited to support their recommendations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpm-2024-0473_abs_003\">\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Current guidelines are based on low-quality evidence that often does not include insights from recent studies and are vague in their recommendations for antenatal hospitalisation and timing of delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpm-2024-0473_abs_004\">\n                    <jats:title>Outlook<\/jats:title>\n                    <jats:p>More robust evidence for management of VP is needed to inform future guidelines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jpm-2024-0473","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T07:31:48Z","timestamp":1736148708000},"page":"411-417","source":"Crossref","is-referenced-by-count":8,"title":["Vasa previa guidelines and their supporting evidence"],"prefix":"10.1515","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5016-903X","authenticated-orcid":false,"given":"Carine","family":"McMahon","sequence":"first","affiliation":[{"name":"Department of Obstetrics & Gynaecology , 2541 Monash University , Melbourne , VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2070-8684","authenticated-orcid":false,"given":"Shelene","family":"Laiu","sequence":"additional","affiliation":[{"name":"School of Clinical Sciences at Monash Health , Melbourne , VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1509-0152","authenticated-orcid":false,"given":"Yinka","family":"Oyelese","sequence":"additional","affiliation":[{"name":"Maternal Fetal Care Center , Boston Children\u2019s Hospital , Boston , MA , USA"},{"name":"Obstetrics and Gynecology , Beth Israel Deaconess Medical Center , Boston , MA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2263-3592","authenticated-orcid":false,"given":"Daniel L.","family":"Rolnik","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynaecology , 2541 Monash University , Melbourne , VIC , Australia"},{"name":"School of Clinical Sciences at Monash Health , Melbourne , VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"2025050303033116268_j_jpm-2024-0473_ref_001","doi-asserted-by":"crossref","unstructured":"Liu, X, Wang, Y, Wu, Y, Zeng, J, Yuan, X, Tong, C, et al.. What we know about placenta accreta spectrum (PAS). Eur J Obstet Gynecol Reprod Biol 2021;259:81\u20139. https:\/\/doi.org\/10.1016\/j.ejogrb.2021.02.001.","DOI":"10.1016\/j.ejogrb.2021.02.001"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_002","doi-asserted-by":"crossref","unstructured":"Bronsteen, R, Whitten, A, Balasubramanian, M, Lee, W, Lorenz, R, Redman, M, et al.. Vasa previa: clinical presentations, outcomes, and implications for management. Obstet Gynecol 2013;122:352\u20137. https:\/\/doi.org\/10.1097\/aog.0b013e31829cac58.","DOI":"10.1097\/AOG.0b013e31829cac58"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_003","doi-asserted-by":"crossref","unstructured":"Oyelese, Y, Javinani, A, Shamshirsaz, AA. Vasa previa. Obstet Gynecol 2023;142:503\u201318. https:\/\/doi.org\/10.1097\/aog.0000000000005287.","DOI":"10.1097\/AOG.0000000000005287"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_004","doi-asserted-by":"crossref","unstructured":"Donnolley, N, Halliday, L, Oyelese, Y. Vasa praevia: a descriptive review of existing literature and the evolving role of ultrasound in prenatal screening. Australas J Ultrasound Med 2013;16:71\u20136. https:\/\/doi.org\/10.1002\/j.2205-0140.2013.tb00168.x.","DOI":"10.1002\/j.2205-0140.2013.tb00168.x"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_005","doi-asserted-by":"crossref","unstructured":"Oyelese, Y, Catanzarite, V, Prefumo, F, Lashley, S, Schachter, M, Tovbin, Y, et al.. Vasa previa: the impact of prenatal diagnosis on outcomes. Obstet Gynecol 2004;103:937\u201342. https:\/\/doi.org\/10.1097\/01.aog.0000123245.48645.98.","DOI":"10.1097\/01.AOG.0000123245.48645.98"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_006","doi-asserted-by":"crossref","unstructured":"Zhang, W, Giacchino, T, Chanyarungrojn, PA, Ionescu, O, Akolekar, R. Incidence of vasa praevia: a systematic review and meta-analysis. BMJ Open 2023;13:e075245. https:\/\/doi.org\/10.1136\/bmjopen-2023-075245.","DOI":"10.1136\/bmjopen-2023-075245"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_007","doi-asserted-by":"crossref","unstructured":"Smorgick, N, Tovbin, Y, Ushakov, F, Vaknin, Z, Barzilay, B, Herman, A, et al.. Is neonatal risk from vasa previa preventable? The 20-year experience from a single medical center. J Clin Ultrasound 2010;38:118\u201322. https:\/\/doi.org\/10.1002\/jcu.20665.","DOI":"10.1002\/jcu.20665"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_008","doi-asserted-by":"crossref","unstructured":"Catanzarite, V, Cousins, L, Daneshmand, S, Schwendemann, W, Casele, H, Adamczak, J, et al.. Prenatally diagnosed vasa previa: a single-institution series of 96 cases. Obstet Gynecol 2016;128:1153\u201361. https:\/\/doi.org\/10.1097\/aog.0000000000001680.","DOI":"10.1097\/AOG.0000000000001680"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_009","doi-asserted-by":"crossref","unstructured":"Robinson, BK, Grobman, WA. Effectiveness of timing strategies for delivery of individuals with placenta previa and accreta. Obstet Gynecol 2010;116:835\u201342. https:\/\/doi.org\/10.1097\/aog.0b013e3181f3588d.","DOI":"10.1097\/AOG.0b013e3181f3588d"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_010","doi-asserted-by":"crossref","unstructured":"Yerlikaya-Schatten, G, Chalubinski, KM, Pils, S, Springer, S, Ott, J. Risk-adapted management for vasa praevia: a retrospective study about individualized timing of caesarean section. Arch Obstet Gynaecol 2019;299:1545\u201350. https:\/\/doi.org\/10.1007\/s00404-019-05125-9.","DOI":"10.1007\/s00404-019-05125-9"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_011","doi-asserted-by":"crossref","unstructured":"Westcott, JM, Simpson, S, Chasen, S, Vieira, L, Stone, J, Doulaveris, G, et al.. Prenatally diagnosed vasa previa: association with adverse obstetrical and neonatal outcomes. Am J Obstet Gynecol MFM 2020;2:100206. https:\/\/doi.org\/10.1016\/j.ajogmf.2020.100206.","DOI":"10.1016\/j.ajogmf.2020.100206"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_012","doi-asserted-by":"crossref","unstructured":"Yeaton-Massey, A, Girsen, AI, Mayo, JA, Blumenfeld, YJ, El-Sayed, YY, Stevenson, DK, et al.. Vasa previa and extreme prematurity: a population-based study. J Perinatol 2019;39:475\u201380. https:\/\/doi.org\/10.1038\/s41372-019-0319-8.","DOI":"10.1038\/s41372-019-0319-8"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_013","doi-asserted-by":"crossref","unstructured":"Degirmenci, Y, Steetskamp, J, Macchiella, D, Hasenburg, A, Hasenburg, A. Vasa previa: a rare obstetric complication-A case series and a literature review. Clin Case Rep 2022;10:e05608. https:\/\/doi.org\/10.1002\/ccr3.5608.","DOI":"10.1002\/ccr3.5608"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_014","doi-asserted-by":"crossref","unstructured":"Villani, LA, Al-Torshi, R, Shah, PS, Kingdom, JC, D\u2019Souza, R, Keunen, J. Inpatient versus outpatient management of pregnancies with vasa previa: a historical cohort study. Acta Obstet Gynecol Scand 2023;102:1558\u201365. https:\/\/doi.org\/10.1111\/aogs.14595.","DOI":"10.1111\/aogs.14595"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_015","doi-asserted-by":"crossref","unstructured":"La Rochelle, F, Allen, A, Werner, E, Nguyen, B, Caughey, A. Antepartum management of vasa previa: are there benefits to hospitalization? Am J Obstet Gynecol 2013;S237.","DOI":"10.1016\/j.ajog.2012.10.719"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_016","doi-asserted-by":"crossref","unstructured":"Laiu, S, McMahon, C, Rolnik, DL. Inpatient versus outpatient management of prenatally diagnosed vasa praevia: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2023;293:156\u201366. https:\/\/doi.org\/10.1016\/j.ejogrb.2023.11.033.","DOI":"10.1016\/j.ejogrb.2023.11.033"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_017","doi-asserted-by":"crossref","unstructured":"Fishel Bartal, M, Sibai, BM, Ilan, H, Katz, S, Schushan Eisen, I, Kassif, E, et al.. Prenatal diagnosis of vasa previa: outpatient versus inpatient management. Am J Perinatol 2019;36:422\u20137. https:\/\/doi.org\/10.1055\/s-0038-1669396.","DOI":"10.1055\/s-0038-1669396"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_018","unstructured":"The royal Australian and New Zealand college of obstetricians and gynaecologists \u2013 women\u2019s health committee. Vasa praevia 2019. https:\/\/ranzcog.edu.au\/wp-content\/uploads\/Vasa-Praevia.pdf."},{"key":"2025050303033116268_j_jpm-2024-0473_ref_019","doi-asserted-by":"crossref","unstructured":"Jauniaux, E, Alfirevic, Z, Bhide, AG, Burton, GJ, Collins, SL, Silver, R, et al.. Vasa praevia: diagnosis and management: Green-top Guideline No. 27b. BJOG 2019;126:e49\u201361. https:\/\/doi.org\/10.1111\/1471-0528.15307.","DOI":"10.1111\/1471-0528.15307"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_020","doi-asserted-by":"crossref","unstructured":"Society of Maternal-Fetal Publications C, Sinkey, RG, Odibo, AO, Dashe, JS. #37: diagnosis and management of vasa previa. Am J Obstet Gynecol 2015;213:615\u20139. https:\/\/doi.org\/10.1016\/j.ajog.2015.08.031.","DOI":"10.1016\/j.ajog.2015.08.031"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_021","doi-asserted-by":"crossref","unstructured":"Jain, V, Gagnon, R. Guideline No. 439: diagnosis and management of vasa previa. J Obstet Gynaecol Can 2023;45:506\u201318. https:\/\/doi.org\/10.1016\/j.jogc.2023.05.009.","DOI":"10.1016\/j.jogc.2023.05.009"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_022","doi-asserted-by":"crossref","unstructured":"Gagnon, R. No. 231-Guidelines for the management of vasa previa. J Obstet Gynaecol Can 2017;39:e415\u201321. https:\/\/doi.org\/10.1016\/j.jogc.2017.08.016.","DOI":"10.1016\/j.jogc.2017.08.016"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_023","doi-asserted-by":"crossref","unstructured":"Gagnon, R, Diagnostic Imaging C, Maternal Fetal Medicine C. Guidelines for the management of vasa previa. J Obstet Gynaecol Can 2009;31:748\u201353. https:\/\/doi.org\/10.1016\/S1701-2163(16)34282-7.","DOI":"10.1016\/S1701-2163(16)34282-7"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_024","doi-asserted-by":"crossref","unstructured":"Sullivan, EA, Javid, N, Duncombe, G, Li, Z, Safi, N, Cincotta, R, et al.. Vasa previa diagnosis, clinical practice, and outcomes in Australia. Obstet Gynecol 2017;130:591\u20138. https:\/\/doi.org\/10.1097\/aog.0000000000002198.","DOI":"10.1097\/AOG.0000000000002198"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_025","doi-asserted-by":"crossref","unstructured":"Silver, RM. Abnormal placentation: placenta previa, vasa previa, and placenta accreta. Obstet Gynecol 2015;126:654\u201368. https:\/\/doi.org\/10.1097\/aog.0000000000001005.","DOI":"10.1097\/AOG.0000000000001005"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_026","doi-asserted-by":"crossref","unstructured":"Oyelese, Y, Smulian, JC. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol 2006;107:927\u201341. https:\/\/doi.org\/10.1097\/01.aog.0000207559.15715.98.","DOI":"10.1097\/01.AOG.0000207559.15715.98"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_027","doi-asserted-by":"crossref","unstructured":"Ruiter, L, Kok, N, Limpens, J, Derks, JB, de Graaf, IM, Mol, BW, et al.. Systematic review of accuracy of ultrasound in the diagnosis of vasa previa. Ultrasound Obstet Gynecol 2015;45:516\u201322. https:\/\/doi.org\/10.1002\/uog.14752.","DOI":"10.1002\/uog.14752"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_028","doi-asserted-by":"crossref","unstructured":"Hasegawa, J, Arakaki, T, Ichizuka, K, Sekizawa, A. Management of vasa previa during pregnancy. J Perinat Med 2015;43:783\u20134. https:\/\/doi.org\/10.1515\/jpm-2014-0047.","DOI":"10.1515\/jpm-2014-0047"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_029","doi-asserted-by":"crossref","unstructured":"Golic, M, Hinkson, L, Bamberg, C, Rodekamp, E, Brauer, M, Sarioglu, N, et al.. Vasa praevia: risk-adapted modification of the conventional management\u2013a retrospective study. Ultraschall Med 2013;34:368\u201376. https:\/\/doi.org\/10.1055\/s-0032-1313167.","DOI":"10.1055\/s-0032-1313167"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_030","doi-asserted-by":"crossref","unstructured":"Sinkey, RG, Odibo, AO. Vasa previa screening strategies: decision and cost-effectiveness analysis. Ultrasound Obstet Gynecol 2018;52:522\u20139. https:\/\/doi.org\/10.1002\/uog.19098.","DOI":"10.1002\/uog.19098"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_031","doi-asserted-by":"crossref","unstructured":"Swank, ML, Garite, TJ, Maurel, K, Das, A, Perlow, JH, Combs, CA, et al.. Vasa previa: diagnosis and management. Am J Obstet Gynecol 2016;215:223.e1\u20136. https:\/\/doi.org\/10.1016\/j.ajog.2016.02.044.","DOI":"10.1016\/j.ajog.2016.02.044"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_032","doi-asserted-by":"crossref","unstructured":"Skoll, A, Boutin, A, Bujold, E, Burrows, J, Crane, J, Geary, M, et al.. No. 364-Antenatal corticosteroid therapy for improving neonatal outcomes. J Obstet Gynaecol Can 2018;40:1219\u201339. https:\/\/doi.org\/10.1016\/j.jogc.2018.04.018.","DOI":"10.1016\/j.jogc.2018.04.018"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_033","doi-asserted-by":"crossref","unstructured":"Oyelese, Y, Spong, C, Fernandez, MA, McLaren, RA. Second trimester low-lying placenta and in-vitro fertilization? Exclude vasa previa. J Matern Fetal Med 2000;9:370\u20132. https:\/\/doi.org\/10.3109\/14767050009018430.","DOI":"10.1002\/1520-6661(200011\/12)9:6<370::AID-MFM1011>3.3.CO;2-5"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_034","doi-asserted-by":"crossref","unstructured":"Conde-Agudelo, A, Romero, R. Predictive accuracy of changes in transvaginal sonographic cervical length over time for preterm birth: a systematic review and metaanalysis. Am J Obstet Gynecol 2015;213:789\u2013801. https:\/\/doi.org\/10.1016\/j.ajog.2015.06.015.","DOI":"10.1016\/j.ajog.2015.06.015"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_035","doi-asserted-by":"crossref","unstructured":"Ghi, T, Contro, E, Martina, T, Piva, M, Morandi, R, Orsini, LF, et al.. Cervical length and risk of antepartum bleeding in women with complete placenta previa. Ultrasound Obstet Gynecol 2009;33:209\u201312. https:\/\/doi.org\/10.1002\/uog.6301.","DOI":"10.1002\/uog.6301"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_036","doi-asserted-by":"crossref","unstructured":"Zaitoun, MM, El Behery, MM, Abd El Hameed, AA, Soliman, BS. Does cervical length and the lower placental edge thickness measurement correlates with clinical outcome in cases of complete placenta previa? Arch Gynecol Obstet 2011;284:867\u201373. https:\/\/doi.org\/10.1007\/s00404-010-1737-1.","DOI":"10.1007\/s00404-010-1737-1"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_037","doi-asserted-by":"crossref","unstructured":"Mimura, T, Hasegawa, J, Nakamura, M, Matsuoka, R, Ichizuka, K, Sekizawa, A, et al.. Correlation between the cervical length and the amount of bleeding during cesarean section in placenta previa. J Obstet Gynaecol Res 2011;37:830\u20135. https:\/\/doi.org\/10.1111\/j.1447-0756.2010.01446.x.","DOI":"10.1111\/j.1447-0756.2010.01446.x"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_038","doi-asserted-by":"crossref","unstructured":"Sekiguchi, A, Nakai, A, Okuda, N, Inde, Y, Takeshita, T. Consecutive cervical length measurements as a predictor of preterm cesarean section in complete placenta previa. J Clin Ultrasound 2015;43:17\u201322. https:\/\/doi.org\/10.1002\/jcu.22205.","DOI":"10.1002\/jcu.22205"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_039","doi-asserted-by":"crossref","unstructured":"Maymon, R, Melcer, Y, Tovbin, J, Pekar-Zlotin, M, Smorgick, N, Jauniaux, E. The rate of cervical length shortening in the management of vasa previa. J Ultrasound Med 2018;37:717\u201323. https:\/\/doi.org\/10.1002\/jum.14411.","DOI":"10.1002\/jum.14411"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_040","doi-asserted-by":"crossref","unstructured":"Jauniaux, E, Melcer, Y, Maymon, R. Prenatal diagnosis and management of vasa previa in twin pregnancies: a case series and systematic review. Am J Obstet Gynecol 2017;216:568\u201375. https:\/\/doi.org\/10.1016\/j.ajog.2017.01.029.","DOI":"10.1016\/j.ajog.2017.01.029"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_041","doi-asserted-by":"crossref","unstructured":"Society for Maternal-Fetal Medicine, Lauder, J, Sciscione, A, Biggio, J, Osmundson, S. Society for maternal-fetal medicine consult series #50: the role of activity restriction in obstetric management: (replaces consult number 33, august 2014). Am J Obstet Gynecol 2020;223:B2\u201310. https:\/\/doi.org\/10.1016\/j.ajog.2020.04.031.","DOI":"10.1016\/j.ajog.2020.04.031"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_042","doi-asserted-by":"crossref","unstructured":"Mitchell, SJ, Ngo, G, Maurel, KA, Hasegawa, J, Arakaki, T, Melcer, Y, et al.. Timing of birth and adverse pregnancy outcomes in cases of prenatally diagnosed vasa previa: a systematic review and meta-analysis. Am J Obstet Gynecol 2022;227:173\u201381.e24. https:\/\/doi.org\/10.1016\/j.ajog.2022.03.006.","DOI":"10.1016\/j.ajog.2022.03.006"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_043","doi-asserted-by":"crossref","unstructured":"Tsakiridis, I, Mamopoulos, A, Athanasiadis, A, Dagklis, T. Diagnosis and management of vasa previa: a comparison of 4 national guidelines. Obstet Gynecol Surv 2019;74:436\u201342. https:\/\/doi.org\/10.1097\/ogx.0000000000000692.","DOI":"10.1097\/OGX.0000000000000692"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_044","doi-asserted-by":"crossref","unstructured":"Oyelese, Y. Vasa Previa: outpatient management in low-risk asymptomatic patients is reasonable. Eur J Obstet Gynecol Reprod Biol 2024;293:167\u20138. https:\/\/doi.org\/10.1016\/j.ejogrb.2023.12.017.","DOI":"10.1016\/j.ejogrb.2023.12.017"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_045","doi-asserted-by":"crossref","unstructured":"Heyborne, K. Perinatal mortality despite prenatal diagnosis of vasa previa: a systematic review. Obstet Gynecol 2023;142:519\u201328. https:\/\/doi.org\/10.1097\/aog.0000000000005296.","DOI":"10.1097\/AOG.0000000000005296"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_046","doi-asserted-by":"crossref","unstructured":"vConyers, S, Oyelese, Y, Javinani, A, Jamali, M, Zargarzadeh, N, Akolekar, R, et al.. Incidence and causes of perinatal death in prenatally diagnosed vasa previa: a systematic review and meta-analysis. Am J Obstet Gynecol 2024;230:58\u201365. https:\/\/doi.org\/10.1016\/j.ajog.2023.06.015.","DOI":"10.1016\/j.ajog.2023.06.015"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_047","doi-asserted-by":"crossref","unstructured":"Zhang, W, Geris, S, Beta, J, Ramadan, G, Nicolaides, KH, Akolekar, R. Prevention of stillbirth: impact of two-stage screening for vasa previa. Ultrasound Obstet Gynecol: Off J Int Soc Ultrasound Obstet Gynecol 2020;55:605\u201312. https:\/\/doi.org\/10.1002\/uog.21953.","DOI":"10.1002\/uog.21953"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_048","doi-asserted-by":"crossref","unstructured":"Green, A, Chiu, S, Manor, E, Smith, L, Oyelese, Y. The association of gestational age at delivery with neonatal outcomes in prenatally diagnosed vasa previa. J Matern Fetal Neonatal Med 2022;35:10162\u20137. https:\/\/doi.org\/10.1080\/14767058.2022.2122040.","DOI":"10.1080\/14767058.2022.2122040"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_049","doi-asserted-by":"crossref","unstructured":"Guerini, C, Goffinet, F, Marchand-Martin, L, Delorme, P, Pierrat, V, Ancel, PY, et al.. Timing of antenatal corticosteroids and survival without neurologic disabilities at 5(1\/2) years in children born before 35\u00a0weeks of gestation. Am J Obstet Gynecol 2023;229:675.e1\u201318. https:\/\/doi.org\/10.1016\/j.ajog.2023.06.047.","DOI":"10.1016\/j.ajog.2023.06.047"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_050","doi-asserted-by":"crossref","unstructured":"Battarbee, AN, Ros, ST, Esplin, MS, Biggio, J, Bukowski, R, Parry, S, et al.. Optimal timing of antenatal corticosteroid administration and preterm neonatal and early childhood outcomes. Am J Obstet Gynecol MFM 2020;2:100077. https:\/\/doi.org\/10.1016\/j.ajogmf.2019.100077.","DOI":"10.1016\/j.ajogmf.2019.100077"},{"key":"2025050303033116268_j_jpm-2024-0473_ref_051","doi-asserted-by":"crossref","unstructured":"Oyelese, Y, Javinani, A, Gudanowski, B, Krispin, E, Rebarber, A, Akolekar, R, et al.. Vasa previa in singleton pregnancies: diagnosis and clinical management based on an international expert consensus. Am J Obstet Gynecol 2024;31:638.e1\u2013e24. https:\/\/doi.org\/10.1016\/j.ajog.2024.03.013.","DOI":"10.1016\/j.ajog.2024.03.013"}],"container-title":["Journal of Perinatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2024-0473\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2024-0473\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T23:05:40Z","timestamp":1746227140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2024-0473\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":51,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,2]]},"published-print":{"date-parts":[[2025,5,26]]}},"alternative-id":["10.1515\/jpm-2024-0473"],"URL":"https:\/\/doi.org\/10.1515\/jpm-2024-0473","relation":{},"ISSN":["0300-5577","1619-3997"],"issn-type":[{"value":"0300-5577","type":"print"},{"value":"1619-3997","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]}}}